General Xenobiochemistry Utility of in vitro and in vivo systems for studying the permeability of capsaicin and nonivamide through different intestinal regions
Lian Duan, Huaidong Peng, Guangcan Li, Ruolun Wang & Yanfang Chen
Pages: 541-545 | DOI: 10.1080/00498254.2017.1344790
In vitro metabolism of alectinib, a novel potent ALK inhibitor, in human: contribution of CYP3A enzymes
Toshito Nakagawa, Stephen Fowler, Kenji Takanashi, Kuresh Youdim, Tsuyoshi Yamauchi, Kosuke Kawashima, Mika Sato-Nakai, Li Yu & Masaki Ishigai
Pages: 546-554 | DOI: 10.1080/00498254.2017.1344910
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450
Alex McCormick, Helen Swaisland, Venkatesh Pilla Reddy, Maria Learoyd & Graeme Scarfe
Pages: 555-564 | DOI: 10.1080/00498254.2017.1346332
Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants
Tsutomu Shimada, Norie Murayama, Kensaku Kakimoto, Shigeo Takenaka, Young-Ran Lim, Sora Yeom, Donghak Kim, Hiroshi Yamazaki, F. Peter Guengerich & Masayuki Komori
Pages: 565-575 | DOI: 10.1080/00498254.2017.1347306
Altered hepatic drug-metabolizing activity in rats suffering from hypoxemia with experimentally induced acute lung impairment
Yuki Hori, Yasumasa Shimizu & Tetsuya Aiba
Pages: 576-583 | DOI: 10.1080/00498254.2017.1349969
Clinical Pharmacokinetics and Metabolism Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans
Shiyao Xu, Dan Tatosian, Ian Mcintosh, Maria Caceres, Catherine Matthews, Koppara Samuel, Diana Selverian, Sanjeev Kumar & Eunkyung Kauh
Pages: 584-591 | DOI: 10.1080/00498254.2017.1346333
Disposition, profiling and identification of emixustat and its metabolites in humans
Michael E. Fitzsimmons, Gang Sun, Vladimir Kuksa & Michael J. Reid
Pages: 592-604 | DOI: 10.1080/00498254.2017.1350889
Animal Pharmacokinetics and Metabolism Profiling and identification of chlorogenic acid metabolites in rats by ultra-high-performance liquid chromatography coupled with linear ion trap-Orbitrap mass spectrometer
Fei Wang, Zhanpeng Shang, Lulu Xu, Zhibin Wang, Wenjing Zhao, XiaoDan Mei, Jianqiu Lu & Jia Yu Zhang
Pages: 605-617 | DOI: 10.1080/00498254.2017.1343963
Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids
Monika Židková, Igor Linhart, Marie Balíková, Michal Himl, Veronika Dvořáčková, Eva Lhotková & Tomáš Páleníček
Pages: 618-625 | DOI: 10.1080/00498254.2017.1349964
Molecular Toxicology Mass spectrometry-based analysis of murine bronchoalveolar lavage fluid following respiratory exposure to 4,4'-methylene diphenyl diisocyanate aerosol
Justin M. Hettick, Brandon F. Law, Chen-Chung Lin, Adam V. Wisnewski & Paul D. Siegel
Pages: 626-636 | DOI: 10.1080/00498254.2017.1344791
Xenobiotic Transporters In vitro drug–drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes |
Nancy Chen, Donghui Cui, Qing Wang, Zhiming Wen, Richard D. Finkelman & Devin Welty
Pages: 637-646 | DOI: 10.1080/00498254.2017.1344911
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου